AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 06/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $3.40 | Day High | $3.40 | Day Low | $3.34 | |||
| Daily Volume | 481275 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $3.35 | 5298 | 0 | $3.38 | 21106 | |
Directors & Senior Management
| Mr. Andrew McGill | Chairman |
| Mr. Ben Skilbeck | CEO & Director |
| Mr. Brett A. Spork | Non-Executive Director |
| Mr. Thomas Charles Dobson Millner | Non-Executive Director |
| Ms. Ursula E. Kay | Company Secretary and Alternate Director |
Data source: ADVFN
